The Asia-Pacific Glufosinate Market is valued at USD 381 Million in 2021 and expected to be growing at a CAGR of 9.12%, with a projected market of USD 600 Million in 2026. The market shows an enormous potential in the forecast period 2022 - 2027. As a result of factors like glufosinate’s broad weed spectrum and high efficacy, the marker is likely to gain momentum. Glufosinate finds varied applications in both non-agricultural and agricultural sectors.
Glufosinate is a form of herbicide that has high effectiveness and is generally used for weed control in different crops types all over the Asia-Pacific region. Farmers depend on Glufosinate because of its high degree of crop safety and vast area of effect avoiding the need for different types of herbicides for different kind of weeds in a given crop.
Drivers and Restraints:
The increase in the demand for Glufosinate as a substitute to paraquat and glyphosate has led to the Glufosinate market to exhibit immense potential recently. Other key factors driving the Glufosinate market include, herbicide contribution in securing food bowl, GM crop acceptance and approval trend and steady expansion of herbicide tolerant crops usage. The market also faces some restraints and challenges which hold it back from showing even higher growth. Some of the important ones include, stringent government regulations, toxic effects of Glufosinate.
Genetically modified crops
Based on geography, the Asia-Pacific market is analysed under various regions namely
Some of the major companies dominating the Glufosinate market include Bayer AG, The Dow Chemical Company, E. I. du Pont de Nemours and Company, Syngenta AG, Jiangsu Huangma Agrochemicals Co Ltd., Nufarm Ltd, UPL, Jiangsu Seven continent Green Chemical Co Ltd., Hebei Veyong Bio-Chemical Co Ltd., and Zhejiang Yongnong Chem. Ind. Co. Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com